Phibro Animal Health Corp
NASDAQ:PAHC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Thai Beverage PCL
SGX:Y92
|
TH |
|
Seiren Co Ltd
TSE:3569
|
JP |
|
Ten Ren Tea Co Ltd
TWSE:1233
|
TW |
|
C
|
China Water Industry Group Ltd
HKEX:1129
|
HK |
|
R
|
Radiant Logistics Inc
AMEX:RLGT
|
US |
|
Enerpac Tool Group Corp
NYSE:EPAC
|
US |
|
E
|
Etga Group Ltd
TASE:ETGA
|
IL |
|
B
|
BYGGFAKTA GROUP Nordic HoldCo AB
LSE:0AAC
|
SE |
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| US |
|
Phibro Animal Health Corp
NASDAQ:PAHC
|
2.4B USD |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
878.2B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
573B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
232.5B GBP |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
297.3B USD |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
233.6B CHF |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
155.5B USD |
Loading...
|
|
| UK |
|
GlaxoSmithKline PLC
LSE:GSK
|
88.4B GBP |
Loading...
|
Market Distribution
| Min | -24 813% |
| 30th Percentile | 28.9% |
| Median | 43% |
| 70th Percentile | 60.5% |
| Max | 10 905 714.3% |
Other Profitability Ratios
Phibro Animal Health Corp
Glance View
Phibro Animal Health Corp. engages in the manufacture and supply of animal health and mineral nutrition products. The company is headquartered in Teaneck, New Jersey and currently employs 1,725 full-time employees. The company went IPO on 2014-04-11. The firm operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The firm develops, manufactures and markets a range of products for food animals, including poultry, swine, beef and dairy cattle, and aquaculture. The firm sells animal health and mineral nutrition products either directly to integrated poultry, swine and cattle producers or through commercial animal feed manufacturers, wholesalers and distributors. Its Medicated Feed Additives (MFAs) and other business consist of concentrated medicated products, which are administered through animal feeds. The firm's MFAs and other business consists of the production and sale of antibacterials, including Stafac, Terramycin, Neo-Terramycin and Mecadox and anticoccidials, including Nicarb, Aviax, Aviax Plus, Coxistac and amprolium.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for Phibro Animal Health Corp is 32.6%, which is above its 3-year median of 31.2%.
Over the last 3 years, Phibro Animal Health Corp’s Gross Margin has increased from 30.5% to 32.6%. During this period, it reached a low of 30.3% on Mar 31, 2024 and a high of 32.6% on Jan 1, 2026.
